Rda Financial Network Eli Lilly & CO Transaction History

Rda Financial Network

$317 Million
Q3 2024

A detailed history of Rda Financial Network transactions in Eli Lilly & CO stock. As of the latest transaction made, Rda Financial Network holds 4,333 shares of LLY stock, worth $3.45 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

4,333

Previous 4,366 0.76%

Holding current value

$3.45 Million

Previous $3.95 Million 2.88%

% of portfolio

1.21%

Previous 1.32%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$772.14 - $960.02 $25,480 - $31,680	-33 Reduced 0.76%	4,333 $3.84 Million
Q2 2024 Jul 10, 2024	BUY	$724.87 - $909.04 $12,322 - $15,453	17 Added 0.39%	4,366 $3.95 Million
Q1 2024 Apr 11, 2024	BUY	$592.2 - $792.28 $191,872 - $256,698	324 Added 8.05%	4,349 $3.38 Million
Q4 2023 Jan 12, 2024	SELL	$525.19 - $619.13 $2,625 - $3,095	-5 Reduced 0.12%	4,025 $2.35 Million
Q3 2023 Oct 18, 2023	SELL	$434.7 - $599.3 $144,755 - $199,566	-333 Reduced 7.63%	4,030 $2.16 Million
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $51,558 - $68,940	-147 Reduced 3.26%	4,363 $2.05 Million
Q1 2023 Apr 12, 2023	BUY	$310.63 - $364.82 $85,733 - $100,690	276 Added 6.52%	4,510 $1.55 Million
Q4 2022 Jan 10, 2023	BUY	$321.55 - $374.67 $327,337 - $381,414	1,018 Added 31.65%	4,234 $0
Q3 2022 Oct 11, 2022	BUY	$296.48 - $337.87 $37,060 - $42,233	125 Added 4.04%	3,216 $1.04 Million
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $134,905 - $158,398	-484 Reduced 13.54%	3,091 $1 Million
Q1 2022 Apr 12, 2022	BUY	$234.69 - $291.66 $39,897 - $49,582	170 Added 4.99%	3,575 $1.02 Million
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $88,815 - $110,220	395 Added 13.12%	3,405 $941,000
Q3 2021 Oct 29, 2021	BUY	$221.6 - $272.71 $28,808 - $35,452	130 Added 4.51%	3,010 $695,000
Q2 2021 Jul 13, 2021	BUY	$180.55 - $233.54 $54,887 - $70,996	304 Added 11.8%	2,880 $661,000
Q1 2021 May 06, 2021	BUY	$164.32 - $212.72 $30,399 - $39,353	185 Added 7.74%	2,576 $481,000
Q4 2020 Feb 05, 2021	BUY	$130.46 - $172.63 $311,929 - $412,758	2,391 New	2,391 $404,000
Q3 2020 Oct 13, 2020	SELL	$146.22 - $169.13 $184,090 - $212,934	-1,259 Closed	0 $0
Q2 2020 Jul 14, 2020	BUY	$136.42 - $164.18 $171,752 - $206,702	1,259 New	1,259 $207,000
Q1 2020 Apr 06, 2020	SELL	$119.05 - $147.35 $173,336 - $214,541	-1,456 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$106.92 - $132.43 $155,675 - $192,818	1,456 New	1,456 $204,000
Q2 2019 Jul 09, 2019	SELL	$110.79 - $129.32 $179,369 - $209,369	-1,619 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$111.31 - $131.02 $180,210 - $212,121	1,619 New	1,619 $201,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rda Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on Rda Financial Network with notifications on news.

Account

Rda Financial Network Eli Lilly & CO Transaction History